A Real-world Study Cohort of Postmenopausal Women With Osteoporosis Taking Zoledronic Acid or Oral Bisphosphonates.

Trial Profile

A Real-world Study Cohort of Postmenopausal Women With Osteoporosis Taking Zoledronic Acid or Oral Bisphosphonates.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Mar 2016

At a glance

  • Drugs Bisphosphonates; Zoledronic acid
  • Indications Fracture; Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Acronyms IVORY
  • Sponsors Novartis Pharmaceuticals
  • Most Recent Events

    • 03 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Apr 2012 Planned End Date changed from 1 Dec 2014 to 1 Mar 2014 as reported by ClinicalTrials.gov.
    • 20 Sep 2011 Interim 1-year results presented at the 33rd Annual Meeting of the American Society for Bone and Mineral Research.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top